Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Apr 12, 2019
Date Accepted: Nov 26, 2019

The final, peer-reviewed published version of this preprint can be found here:

A Brief Mobile-Augmented Suicide Prevention Intervention for People With Psychotic Disorders in Transition From Acute to Ongoing Care: Protocol for a Pilot Trial

Depp C, Ehret B, Villa J, Perivoliotis D, Granholm E

A Brief Mobile-Augmented Suicide Prevention Intervention for People With Psychotic Disorders in Transition From Acute to Ongoing Care: Protocol for a Pilot Trial

JMIR Res Protoc 2021;10(2):e14378

DOI: 10.2196/14378

PMID: 33555265

PMCID: 7899804

Brief Mobile Augmented Suicide Prevention for People with Psychotic Disorders in Transition from Acute to Ongoing Care: Trial Protocol

  • Colin Depp; 
  • Blaire Ehret; 
  • Jennifer Villa; 
  • Dimitri Perivoliotis; 
  • Eric Granholm

ABSTRACT

Background:

People with serious mental illnesses are at exceptionally high risk for lifetime suicidal ideation and behavior, with rates higher than that in the general population. The transition period between urgent evaluation and ongoing care could provide an important setting for brief suicide-specific intervention for SMI. To address this concern, this trial, SafeTy and Recovery Therapy (START), involves a brief suicide-specific intervention cognitive behavioral intervention for SMI that is augmented with smartphone interactions.

Objective:

The primary objective of this pilot trial is to evaluate the feasibility, acceptability, and preliminary effectiveness of the intervention.

Methods:

Six-month pilot trial with 70 participants with a diagnosis of bipolar disorder, schizophrenia, or schizoaffective disorder and current active suicidal ideation were randomized to START or START + Mobile Augmentation. START consists of 4 weekly sessions addressing early warning signs/triggers, symptoms “drivers” of suicidal thinking, social relationships. And recovery planning and is followed by bi-weekly telephone coaching. START+Mobile Augmentation includes personalized automated CBT scripts that build from in-person content. Participants are evaluated at baseline, 4 weeks (end of in-person sessions), 12 weeks (end of telephone coaching) and 24 weeks. In addition to providing point estimates of feasibility and acceptability, the primary outcome of the trial is change in severity of suicidal ideation as measured with the Scale for Suicide Ideation (SSI) and secondary outcomes include the rate of outpatient engagement.

Results:

The trial is ongoing. Feasibility and acceptability across conditions will be assessed with t-tests/Mann Whitney tests or Chi-square. Reduction of SSI over time will be assessed with hierarchical linear models.

Conclusions:

The design considerations and results of this trial may be informative for adapted suicide prevention in psychotic disorders in applied community settings. Clinical Trial: NCT03198364


 Citation

Please cite as:

Depp C, Ehret B, Villa J, Perivoliotis D, Granholm E

A Brief Mobile-Augmented Suicide Prevention Intervention for People With Psychotic Disorders in Transition From Acute to Ongoing Care: Protocol for a Pilot Trial

JMIR Res Protoc 2021;10(2):e14378

DOI: 10.2196/14378

PMID: 33555265

PMCID: 7899804

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.